1 Min Read
Nov 21 (Reuters) - BIOVICA INTERNATIONAL AB
* NEW STUDY RESULTS SUPPORT EVALUATION WITH DIVITUM IN TREATMENT OF PANCREATIC CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.